Humacyte plans ATEV supplemental BLA filing for dialysis access
Humacyte says it plans a supplemental BLA filing for ATEV in dialysis access following FDA discussions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.